Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Comparative efficacy of linezolid and vancomycin for endotracheal tube MRSA biofilms from ICU patients.

Fernández-Barat L, Motos A, Panigada M, Álvarez-Lerma F, Viña L, Lopez-Aladid R, Ceccato A, Bassi GL, Nicolau DP, Lopez Y, Muñoz L, Guerrero L, Soy D, Israel T, Castro P, Torres A.

Crit Care. 2019 Jul 10;23(1):251. doi: 10.1186/s13054-019-2523-5.

2.

Exposure-response modeling of tocilizumab in rheumatoid arthritis using continuous composite measures and their individual components.

Bastida C, Soy D, Ruiz-Esquide V, Sanmartí R, Huitema ADR.

Br J Clin Pharmacol. 2019 Aug;85(8):1710-1718. doi: 10.1111/bcp.13954. Epub 2019 Jun 17.

PMID:
30958574
3.

Role of age and comorbidities in mortality of patients with infective endocarditis.

Armiñanzas C, Fariñas-Alvarez C, Zarauza J, Muñoz P, González Ramallo V, Martínez Sellés M, Miró Meda JM, Pericás JM, Goenaga MÁ, Ojeda Burgos G, Rodríguez Álvarez R, Castelo Corral L, Gálvez-Acebal J, Martínez Marcos FJ, Fariñas MC; Spanish Collaboration on Endocarditis — Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en Espana Study Group, Fernández Sánchez F, Noureddine M, Rosas G, de la Torre Lima J, Aramendi J, Bereciartua E, Blanco MJ, Blanco R, Boado MV, Campaña Lázaro M, Crespo A, Goikoetxea J, Iruretagoyena JR, Irurzun Zuazabal J, López-Soria L, Montejo M, Nieto J, Rodrigo D, Rodríguez D, Rodríguez R, Vitoria Y, Voces R, García López MV, Georgieva RI, Ojeda G, Rodríguez Bailón I, Ruiz Morales J, Cuende AM, Echeverría T, Fuerte A, Gaminde E, Goenaga MÁ, Idígoras P, Iribarren JA, Izaguirre Yarza A, Kortajarena Urkola X, Reviejo C, Carrasco R, Climent V, Llamas P, Merino E, Plazas J, Reus S, Álvarez N, Bravo-Ferrer JM, Castelo L, Cuenca J, Llinares P, Miguez Rey E, Rodríguez Mayo M, Sánchez E, Sousa Regueiro D, Martínez FJ, Alonso MDM, Castro B, García Rosado D, Durán MDC, Miguel Gómez MA, Lacalzada J, Nassar I, Plata Ciezar A, Reguera Iglesias JM, Asensi Álvarez V, Costas C, de la Hera J, Fernández Suárez J, Iglesias Fraile L, León Arguero V, López Menéndez J, Mencia Bajo P, Morales C, Moreno Torrico A, Palomo C, Paya Martínez B, Rodríguez Esteban Á, Rodríguez García R, Telenti Asensio M, Almela M, Ambrosioni J, Azqueta M, Brunet M, Bodro M, Cartañá R, Falces C, Fita G, Fuster D, García de la Mària C, Hernández-Meneses M, Llopis Pérez J, Marco F, Miró JM, Moreno A, Nicolás D, Ninot S, Quintana E, Paré C, Pereda D, Pericás JM, Pomar JL, Ramírez J, Rovira I, Sandoval E, Sitges M, Soy D, Téllez A, Tolosana JM, Vidal B, Vila J, Adán I, Bermejo J, Bouza E, Celemín D, Cuerpo Caballero G, Delgado Montero A, Fernández Cruz A, García Mansilla A, García Leoni ME, González Ramallo V, Kestler Hernández M, Hualde AM, Marín M, Martínez-Sellés M, Menárguez MC, Muñoz P, Rincón C, Rodríguez-Abella H, Rodríguez-Créixems M, Pinilla B, Pinto Á, Valerio M, Vázquez P, Verde Moreno E, Antorrena I, Loeches B, Martín Quirós A, Moreno M, Ramírez U, Rial Bastón V, Romero M, Saldaña A, Agüero Balbín J, Amado C, Armiñanzas Castillo C, Arnaiz García A, Cobo Belaustegui M, Fariñas MC, Fariñas-Álvarez C, Gómez Izquierdo R, García I, González-Rico C, Gutiérrez-Cuadra M, Gutiérrez Díez J, Pajarón M, Parra JA, Sarralde A, Teira R, Zarauza J, Domínguez F, García Pavía P, González J, Orden B, Ramos A, Centella T, Hermida JM, Moya JL, Martín-Dávila P, Navas E, Oliva E, Del Río A, Ruiz S, Hidalgo Tenorio C, Almendro Delia M, Araji O, Barquero JM, Calvo Jambrina R, de Cueto M, Gálvez Acebal J, Méndez I, Morales I, López-Cortés LE, de Alarcón A, García E, Haro JL, Lepe JA, López F, Luque R, Alonso LJ, Azcárate P, Azcona Gutiérrez JM, Blanco JR, García-Álvarez L, Oteo JA, Sanz M, de Benito N, Gurguí M, Pacho C, Pericas R, Pons G, Álvarez M, Fernández AL, Martínez A, Prieto A, Regueiro B, Tijeira E, Vega M, Canut Blasco A, Cordo Mollar J, Gainzarain Arana JC, García Uriarte O, Martín López A, Ortiz de Zárate Z, Urturi Matos JA, García Domínguez G, Sánchez-Porto A, Arribas Leal JM, García Vázquez E, Hernández Torres A, Blázquez A, de la Morena Valenzuela G, Alonso Á, Aramburu J, Calvo FE, Moreno Rodríguez A, Tarabini-Castellani P, Heredero Gálvez E, Maicas Bellido C, Largo Pau J, Sepúlveda MA, Toledano Sierra P, Iqbal-Mirza SZ, Cascales Alcolea E, Egea Serrano P, Hernández Roca JJ, Keituqwa Yañez I, Peláez Ballesta A, Soriano V, Moreno Escobar E, Peña Monje A, Sánchez Cabrera V, Vinuesa García D, Arrizabalaga Asenjo M, Cifuentes Luna C, Núñez Morcillo J, Pérez Seco MC, Villoslada Gelabert A, Aured Guallar C, Fernández Abad N, García Mangas P, Matamala Adell M, Palacián Ruiz MP, Porres JC, Alcaraz Vidal B, Cobos Trigueros N, Del Amor Espín MJ, Giner Caro JA, Jiménez Sánchez R, Jimeno Almazán A, Ortín Freire A, Viqueira González M, Pericás Ramis P, Ribas Blanco MÁ, Ruiz de Gopegui Bordes E, Vidal Bonet L, Bellón Munera MC, Escribano Garaizabal E, Tercero Martínez A, Segura Luque JC.

Eur J Intern Med. 2019 Jun;64:63-71. doi: 10.1016/j.ejim.2019.03.006. Epub 2019 Mar 21.

PMID:
30904433
4.

Clozapine Use During Pregnancy and Lactation: A Case-Series Report.

Imaz ML, Oriolo G, Torra M, Soy D, García-Esteve L, Martin-Santos R.

Front Pharmacol. 2018 Mar 27;9:264. doi: 10.3389/fphar.2018.00264. eCollection 2018.

5.

The Combination of Daptomycin and Fosfomycin Has Synergistic, Potent, and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus in a Rabbit Model of Experimental Endocarditis.

García-de-la-Mària C, Gasch O, García-Gonzalez J, Soy D, Shaw E, Ambrosioni J, Almela M, Pericàs JM, Tellez A, Falces C, Hernandez-Meneses M, Sandoval E, Quintana E, Vidal B, Tolosana JM, Fuster D, Llopis J, Pujol M, Moreno A, Marco F, Miró JM.

Antimicrob Agents Chemother. 2018 May 25;62(6). pii: e02633-17. doi: 10.1128/AAC.02633-17. Print 2018 Jun.

6.

Population pharmacokinetics of daptomycin in critically ill patients.

Soraluce A, Asín-Prieto E, Rodríguez-Gascón A, Barrasa H, Maynar J, Carcelero E, Soy D, Isla A.

Int J Antimicrob Agents. 2018 Aug;52(2):158-165. doi: 10.1016/j.ijantimicag.2018.03.008. Epub 2018 Mar 20.

PMID:
29572042
7.

Tocilizumab in the treatment of adult rheumatoid arthritis.

Sanmartí R, Ruiz-Esquide V, Bastida C, Soy D.

Immunotherapy. 2018 Mar 1;10(6):447-464. doi: 10.2217/imt-2017-0173. Epub 2018 Mar 2. Review.

PMID:
29495891
8.

What to expect and when: benznidazole toxicity in chronic Chagas' disease treatment.

Aldasoro E, Posada E, Requena-Méndez A, Calvo-Cano A, Serret N, Casellas A, Sanz S, Soy D, Pinazo MJ, Gascon J.

J Antimicrob Chemother. 2018 Apr 1;73(4):1060-1067. doi: 10.1093/jac/dkx516.

PMID:
29351667
9.

Fixed dosing of intravenous tocilizumab in rheumatoid arthritis. Results from a population pharmacokinetic analysis.

Bastida C, Ruiz-Esquide V, Pascal M, de Vries Schultink AHM, Yagüe J, Sanmartí R, Huitema ADR, Soy D.

Br J Clin Pharmacol. 2018 Apr;84(4):716-725. doi: 10.1111/bcp.13500. Epub 2018 Feb 7.

10.

AUC/MIC Pharmacodynamic Target Is Not a Good Predictor of Vancomycin Efficacy in Methicillin-Resistant Staphylococcus aureus Experimental Endocarditis.

Castañeda X, García-de-la-Mària C, Gasch O, Pericas JM, Armero Y, Soy D, García-González J, Falces C, Ninot S, Almela M, Ambrosioni J, Quintana E, Vidal B, Fuster D, Llopis J, Soto S, Moreno A, Marco F, Miró JM; Hospital Clinic Endocarditis Study Group.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e02486-16. doi: 10.1128/AAC.02486-16. Print 2017 Jun.

11.

Is there potential for therapeutic drug monitoring of biologic agents in rheumatoid arthritis?

Bastida C, Ruíz V, Pascal M, Yagüe J, Sanmartí R, Soy D.

Br J Clin Pharmacol. 2017 May;83(5):962-975. doi: 10.1111/bcp.13192. Epub 2017 Jan 18. Review.

12.

Effect of mammalian target of rapamycin inhibitors on cytomegalovirus infection in kidney transplant recipients receiving polyclonal antilymphocyte globulins: a propensity score-matching analysis.

Cervera C, Cofan F, Hernandez C, Soy D, Marcos MA, Sanclemente G, Bodro M, Moreno A, Diekmann F, Campistol JM, Oppenheimer F.

Transpl Int. 2016 Nov;29(11):1216-1225. doi: 10.1111/tri.12848. Epub 2016 Sep 26.

13.

Safety and Tolerability of Alveolar Type II Cell Transplantation in Idiopathic Pulmonary Fibrosis.

Serrano-Mollar A, Gay-Jordi G, Guillamat-Prats R, Closa D, Hernandez-Gonzalez F, Marin P, Burgos F, Martorell J, Sánchez M, Arguis P, Soy D, Bayas JM, Ramirez J, Tetley TD, Molins L, de la Bellacasa JP, Rodríguez-Villar C, Rovira I, Fiblà JJ, Xaubet A; Pneumocyte Study Group.

Chest. 2016 Sep;150(3):533-43. doi: 10.1016/j.chest.2016.03.021. Epub 2016 Mar 25.

PMID:
27020420
14.

Piperacillin population pharmacokinetics in critically ill patients with multiple organ dysfunction syndrome receiving continuous venovenous haemodiafiltration: effect of type of dialysis membrane on dosing requirements.

Ulldemolins M, Martín-Loeches I, Llauradó-Serra M, Fernández J, Vaquer S, Rodríguez A, Pontes C, Calvo G, Torres A, Soy D.

J Antimicrob Chemother. 2016 Jun;71(6):1651-9. doi: 10.1093/jac/dkv503. Epub 2016 Feb 10.

PMID:
26869692
15.

Predictive performance of glomerular filtration rate estimation equations based on cystatin C versus serum creatinine values in critically ill patients.

Diego E, Castro P, Soy D, Poch E, Nicolás JM.

Am J Health Syst Pharm. 2016 Feb 15;73(4):206-15. doi: 10.2146/ajhp140852.

PMID:
26843497
16.

Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus.

del Río A, García-de-la-Mària C, Entenza JM, Gasch O, Armero Y, Soy D, Mestres CA, Pericás JM, Falces C, Ninot S, Almela M, Cervera C, Gatell JM, Moreno A, Moreillon P, Marco F, Miró JM; Hospital Clinic Experimental Endocarditis Study Group.

Antimicrob Agents Chemother. 2015 Nov 2;60(1):478-86. doi: 10.1128/AAC.02139-15. Print 2016 Jan.

17.

Meropenem population pharmacokinetics in critically ill patients with septic shock and continuous renal replacement therapy: influence of residual diuresis on dose requirements.

Ulldemolins M, Soy D, Llaurado-Serra M, Vaquer S, Castro P, Rodríguez AH, Pontes C, Calvo G, Torres A, Martín-Loeches I.

Antimicrob Agents Chemother. 2015 Sep;59(9):5520-8. doi: 10.1128/AAC.00712-15. Epub 2015 Jun 29.

18.

Epidemiology and prognosis of coagulase-negative staphylococcal endocarditis: impact of vancomycin minimum inhibitory concentration.

García de la Mària C, Cervera C, Pericàs JM, Castañeda X, Armero Y, Soy D, Almela M, Ninot S, Falces C, Mestres CA, Gatell JM, Moreno A, Marco F, Miró JM; Hospital Clinic Endocarditis Study Group.

PLoS One. 2015 May 11;10(5):e0125818. doi: 10.1371/journal.pone.0125818. eCollection 2015.

19.

Population pharmacokinetics of benznidazole in adult patients with Chagas disease.

Soy D, Aldasoro E, Guerrero L, Posada E, Serret N, Mejía T, Urbina JA, Gascón J.

Antimicrob Agents Chemother. 2015;59(6):3342-9. doi: 10.1128/AAC.05018-14. Epub 2015 Mar 30.

20.

Efficacy and safety of fosfomycin plus imipenem as rescue therapy for complicated bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: a multicenter clinical trial.

del Río A, Gasch O, Moreno A, Peña C, Cuquet J, Soy D, Mestres CA, Suárez C, Pare JC, Tubau F, Garcia de la Mària C, Marco F, Carratalà J, Gatell JM, Gudiol F, Miró JM; FOSIMI Investigators.

Clin Infect Dis. 2014 Oct 15;59(8):1105-12. doi: 10.1093/cid/ciu580. Epub 2014 Jul 21.

PMID:
25048851
21.

Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy.

Ulldemolins M, Vaquer S, Llauradó-Serra M, Pontes C, Calvo G, Soy D, Martín-Loeches I.

Crit Care. 2014 Jun 23;18(3):227. doi: 10.1186/cc13938. Review.

22.

Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone.

Pericas JM, Cervera C, del Rio A, Moreno A, Garcia de la Maria C, Almela M, Falces C, Ninot S, Castañeda X, Armero Y, Soy D, Gatell JM, Marco F, Mestres CA, Miro JM; Hospital Clinic Endocarditis Study Group.

Clin Microbiol Infect. 2014 Dec;20(12):O1075-83. doi: 10.1111/1469-0691.12756. Epub 2014 Aug 11.

23.

Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis.

Cervera C, Castañeda X, de la Maria CG, del Rio A, Moreno A, Soy D, Pericas JM, Falces C, Armero Y, Almela M, Ninot S, Pare JC, Mestres CA, Gatell JM, Marco F, Miro JM; Hospital Clinic Endocarditis Study Group.

Clin Infect Dis. 2014 Jun;58(12):1668-75. doi: 10.1093/cid/ciu183. Epub 2014 Mar 18.

PMID:
24647021
24.

Caecal diverticulitis mimicking acute appendicitis.

Buluş H, Koyuncu A, Taş A, Köklü S, Soy D, Coşkun A.

Turk J Gastroenterol. 2013;24(4):371-2. No abstract available.

25.

Activity and interactions of levofloxacin, linezolid, ethambutol and amikacin in three-drug combinations against Mycobacterium tuberculosis isolates in a human macrophage model.

Rey-Jurado E, Tudó G, Soy D, González-Martín J.

Int J Antimicrob Agents. 2013 Dec;42(6):524-30. doi: 10.1016/j.ijantimicag.2013.07.014. Epub 2013 Sep 5.

PMID:
24080479
26.

[Guidelines for antimicrobial treatment of the infection by Staphylococcus aureus].

Mensa J, Soriano A, Llinares P, Barberán J, Montejo M, Salavert M, Alvarez-Rocha L, Maseda E, Moreno A, Pasquau J, Gómez J, Parra J, Candel J, Azanza JR, García JE, Marco F, Soy D, Grau S, Arias J, Fortún J, de Alarcón CA, Picazo J; Sociedad Española de Quimioterapia (SEQ); Sociedad Española de Medicina Interna (SEMI); GTIPO-Sociedad Española de Anestesiología y Reanimación.

Rev Esp Quimioter. 2013 Jan;26 Suppl 1:1-84. Review. Spanish. No abstract available.

27.

Early in vitro and in vivo development of high-level daptomycin resistance is common in mitis group Streptococci after exposure to daptomycin.

García-de-la-Mària C, Pericas JM, Del Río A, Castañeda X, Vila-Farrés X, Armero Y, Espinal PA, Cervera C, Soy D, Falces C, Ninot S, Almela M, Mestres CA, Gatell JM, Vila J, Moreno A, Marco F, Miró JM; Hospital Clinic Experimental Endocarditis Study Group.

Antimicrob Agents Chemother. 2013 May;57(5):2319-25. doi: 10.1128/AAC.01921-12. Epub 2013 Mar 11.

28.

Can the efficiency of modified Alvarado scoring system in the diagnosis acute appendicitis be increased with tenesmus?

Bulus H, Tas A, Morkavuk B, Koklu S, Soy D, Coskun A.

Wien Klin Wochenschr. 2013 Jan;125(1-2):16-20. doi: 10.1007/s00508-012-0308-9. Epub 2013 Jan 5.

PMID:
23292641
29.

Benznidazole-related adverse drug reactions and their relationship to serum drug concentrations in patients with chronic chagas disease.

Pinazo MJ, Guerrero L, Posada E, Rodríguez E, Soy D, Gascon J.

Antimicrob Agents Chemother. 2013 Jan;57(1):390-5. doi: 10.1128/AAC.01401-12. Epub 2012 Oct 31.

30.

[Flecainide intoxication].

Nogué S, Cino J, Corominas N, Soy D.

Med Clin (Barc). 2013 Jan 5;140(1):46. doi: 10.1016/j.medcli.2012.05.038. Epub 2012 Sep 29. Spanish. No abstract available.

PMID:
23026721
31.

Linezolid limits burden of methicillin-resistant Staphylococcus aureus in biofilm of tracheal tubes.

Fernández-Barat L, Ferrer M, Sierra JM, Soy D, Guerrero L, Vila J, Li Bassi G, Cortadellas N, Martínez-Olondris P, Rigol M, Esperatti M, Luque N, Saucedo LM, Agustí C, Torres A.

Crit Care Med. 2012 Aug;40(8):2385-9. doi: 10.1097/CCM.0b013e31825332fc.

PMID:
22622402
32.

[Antibiotic dose adjustment in the treatment of MRSA infections in patients with acute renal failure undergoing continuous renal replacement therapies].

Carcelero E, Soy D.

Enferm Infecc Microbiol Clin. 2012 May;30(5):249-56. doi: 10.1016/j.eimc.2011.09.013. Epub 2011 Nov 29. Review. Spanish.

PMID:
22130573
33.

Pharmacokinetic study of saquinavir 500 mg plus ritonavir (1000/100 mg twice a day) in HIV-positive pregnant women.

Martinez-Rebollar M, Lonca M, Perez I, Soy D, Brunet M, Martin R, Coll O, Hernandez S, Laguno M, Milinkovic A, Larrousse M, Calvo M, Blanco JL, Martínez E, Gatell JM, Mallolas J.

Ther Drug Monit. 2011 Dec;33(6):772-7. doi: 10.1097/FTD.0b013e318236376d.

PMID:
22105596
34.

Linezolid pharmacokinetics in patients with acute renal failure undergoing continuous venovenous hemodiafiltration.

Carcelero E, Soy D, Guerrero L, Poch E, Fernandez J, Castro P, Ribas J.

J Clin Pharmacol. 2012 Sep;52(9):1430-5. doi: 10.1177/0091270011417717. Epub 2011 Sep 29. No abstract available.

PMID:
21960670
35.

Efficacy of linezolid compared to vancomycin in an experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated pigs.

Martinez-Olondris P, Rigol M, Soy D, Guerrero L, Agusti C, Quera MA, Li Bassi G, Esperatti M, Luque N, Liapikou M, Filella X, Marco F, de la Bellacasa JP, Torres A.

Crit Care Med. 2012 Jan;40(1):162-8. doi: 10.1097/CCM.0b013e31822d74a2.

PMID:
21926613
36.

Pharmacokinetic monitoring of antiepileptic drugs.

Aldaz A, Ferriols R, Aumente D, Calvo MV, Farre MR, García B, Marqués R, Mas P, Porta B, Outeda M, Soy D; Grupo PK-gen de la Sociedad Española de Farmacia Hospitalaria.

Farm Hosp. 2011 Nov-Dec;35(6):326-39. doi: 10.1016/j.farma.2010.10.005. Epub 2011 May 13. Review. English, Spanish.

PMID:
21570885
37.

A high-performance liquid chromatographic method for benznidazole quantitation in plasma of patients with Chagas disease.

Guerrero L, Pinazo MJ, Posada E, Gascón J, Ribas J, Soy D.

Clin Chem Lab Med. 2011 Jan;49(1):77-82. doi: 10.1515/CCLM.2011.014. Epub 2010 Nov 18.

PMID:
21083440
38.

Tolerance of benznidazole in treatment of Chagas' disease in adults.

Pinazo MJ, Muñoz J, Posada E, López-Chejade P, Gállego M, Ayala E, del Cacho E, Soy D, Gascon J.

Antimicrob Agents Chemother. 2010 Nov;54(11):4896-9. doi: 10.1128/AAC.00537-10. Epub 2010 Sep 7.

39.

Daptomycin is effective for treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus epidermidis.

García-de-la-Mària C, Marco F, Armero Y, Soy D, Moreno A, del Río A, Almela M, Cervera C, Ninot S, Falces C, Mestres CA, Gatell JM, Jiménez de Anta MT, Miró JM; Hospital Clínic Experimental Endocarditis Study Group.

Antimicrob Agents Chemother. 2010 Jul;54(7):2781-6. doi: 10.1128/AAC.01011-09. Epub 2010 Apr 26.

40.

An experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated piglets.

Martínez-Olondris P, Sibila O, Agustí C, Rigol M, Soy D, Esquinas C, Piñer R, Luque N, Guerrero L, Quera MÁ, Marco F, de la Bellacasa JP, Ramirez J, Torres A.

Eur Respir J. 2010 Oct;36(4):901-6. doi: 10.1183/09031936.00176709. Epub 2010 Mar 29.

41.

[Measuring linezolid in biological fluids using high-efficiency liquid chromatography].

Guerrero L, Sarasa M, López Y, Soy D.

Farm Hosp. 2010 Jan-Feb;34(1):27-31. doi: 10.1016/j.farma.2009.07.001. Spanish.

PMID:
20144819
42.

Development and validation of a high performance liquid chromatography method to determine linezolid concentrations in pig pulmonary tissue.

Guerrero L, Martínez-Olondris P, Rigol M, Esperatti M, Esquinas C, Luque N, Piñer R, Torres A, Soy D.

Clin Chem Lab Med. 2010 Mar;48(3):391-8. doi: 10.1515/CCLM.2010.078.

43.

Addition of gentamicin or rifampin does not enhance the effectiveness of daptomycin in treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.

Miró JM, García-de-la-Mària C, Armero Y, Soy D, Moreno A, del Río A, Almela M, Sarasa M, Mestres CA, Gatell JM, Jiménez de Anta MT, Marco F; Hospital Clinic Experimental Endocarditis Study Group.

Antimicrob Agents Chemother. 2009 Oct;53(10):4172-7. doi: 10.1128/AAC.00051-09. Epub 2009 Jul 20.

44.

A boy with trisomy 13 presenting with a subtle clinical picture and metopic synostosis.

Unal S, Celik FC, Soy D, Ceylaner S, Ceylaner G.

Am J Med Genet A. 2009 Jul;149A(7):1608-9. doi: 10.1002/ajmg.a.32912. No abstract available.

PMID:
19533776
45.

Variables related to behavioral and emotional problems and gender typed behaviors in female patients with congenital adrenal hyperplasia.

Oner O, Aycan Z, Tiryaki T, Soy D, Cetinkaya E, Kibar E.

J Pediatr Endocrinol Metab. 2009 Feb;22(2):143-51.

PMID:
19449671
46.

Pharmacokinetics of linezolid in human non-inflamed vitreous after systemic administration.

Horcajada JP, Atienza R, Sarasa M, Soy D, Adán A, Mensa J.

J Antimicrob Chemother. 2009 Mar;63(3):550-2. doi: 10.1093/jac/dkn516. Epub 2008 Dec 24.

PMID:
19109336
47.

Population pharmacokinetics of high-dose methotrexate after intravenous administration in pediatric patients with osteosarcoma.

Colom H, Farré R, Soy D, Peraire C, Cendros JM, Pardo N, Torrent M, Domenech J, Mangues MA.

Ther Drug Monit. 2009 Feb;31(1):76-85. doi: 10.1097/FTD.0b013e3181945624.

PMID:
19077931
48.

MEFV mutations modify the clinical presentation of Henoch-Schönlein purpura.

Ozçakar ZB, Yalçinkaya F, Cakar N, Acar B, Kasapçopur O, Ugüten D, Soy D, Kara N, Uncu N, Arisoy N, Ekim M.

J Rheumatol. 2008 Dec;35(12):2427-9. Epub 2008 Oct 1.

PMID:
18843775
49.

[Recommendations for antibiotic monitoring in ICU patients].

Grupo de Estudio de Infección en el paciente crítico (GEIPC-SEIMC); Sociedad Española de Farmacia Hospitalaria; Sociedad Española de Farmacología Clínica; Sociedad Andaluza de Análisis Clínicos (SANAC), Alvarez F, Olaechea P, Grau S, Marín M, Domínguez A, Martínez-Lanao J, Soy D, Alos M, Victoria M, Sádaba B, Mediavilla A, Fatela D.

Farm Hosp. 2008 Mar-Apr;32(2):113-23. Spanish.

PMID:
18783711
50.

Daptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.

Marco F, de la Mària CG, Armero Y, Amat E, Soy D, Moreno A, del Río A, Almela M, Mestres CA, Gatell JM, Jiménez de Anta MT, Miró JM; Hospital Clinic Experimental Endocarditis Study Group.

Antimicrob Agents Chemother. 2008 Jul;52(7):2538-43. doi: 10.1128/AAC.00510-07. Epub 2008 Apr 21.

Supplemental Content

Support Center